7-Day MEMO Patch Monitoring for Arrhythmia Detection in Patients With Palpitations

"This exploratory prospective clinical study aims to evaluate the diagnostic yield of a 7-day adhesive electrocardiographic (ECG) monitoring device (MEMO Patch) in detecting cardiac arrhythmias in patients presenting with palpitations. Participants who require 24-hour Holter monitoring because of symptoms such as palpitations or dizziness will simultaneously wear a conventional 24-hour Holter monitor and the MEMO Patch. The Holter monitor will be removed after 24 hours, while the MEMO Patch will continue monitoring for a total of 7 days. ECG recordings will be evaluated by cardiologists after technical quality assessment. The study will assess arrhythmia detection, device-related skin adverse events, and participant usability and satisfaction."

Inclusion Criteria: * Participants must meet all of the following criteria: 1. Adults aged 19 years or older who visit the study site during the study period with symptoms such as palpitations or syncope and are considered to require 24-hour ambulatory electrocardiographic monitoring. 2. Able and willing to provide voluntary written informed consent. 3. Able to wear the MEMO Patch™ continuously for 7 days. Exclusion Criteria: * Participants meeting any of the following criteria will be excluded: 1. A self-reported history of an allergic skin reaction to previously used adhesive products. 2. Planned electrical cardioversion, catheter ablation, or surgical treatment for an arrhythmia during the study period.